From human biology to biological intelligence.

CellCircuit is an AI-native drug discovery company advancing Human Biology Intelligence for next-generation therapeutic discovery.

We integrate engineered living 3D human disease models, systematic perturbation, spatial and longitudinal pheno-multiomics, and computational intelligence to transform complex biological responses into actionable discovery intelligence.

Our platform is designed to investigate how cells organize, communicate, adapt, and respond to therapeutic interventions across disease-relevant environments, generating biological evidence to investigate causal mechanisms, prioritize therapeutic opportunities, and guide iterative discovery.

Founded by scientists and bioengineers with expertise across advanced human cell systems, biomaterials, tissue engineering, phenomics, computational biology, and translational research, CellCircuit is developing the infrastructure to make human biological responses increasingly measurable, interpretable, and predictable.